How Long Does Semaglutide Take to Work? A Month-by-Month Timeline

Most Houston clinics start semaglutide at the lowest dose, typically 0.25 mg per week for Wegovy, and increase gradually over several months. This titration schedule exists specifically to reduce nausea and GI side effects, not to maximize weight loss. During the first four weeks, don't expect dramatic results on the scale. Some patients notice reduced appetite fairly quickly, while others feel little effect at the starter dose. Weight loss during this phase, if any, is typically modest, one to two pounds per week if dietary habits improve alongside the medication.

As the dose increases (0.5 mg at week 5, 1 mg at week 9 in the standard Wegovy protocol), appetite suppression becomes more noticeable. Patients typically describe feeling full faster, having fewer food cravings, and being less interested in snacking. Clinical data from the STEP 1 trial shows average weight loss of about 5-6% of starting body weight by week 20. For someone starting at 220 pounds, that's roughly 11-13 pounds. Houston providers report that patients who pair semaglutide with dietary coaching and regular activity tend to see results at the higher end of this range.

The 2 mg and 2.4 mg maintenance doses drive the majority of weight loss. The STEP 1 trial showed approximately 10% average weight loss by week 28 and 14.9% by week 68. In real-world Houston clinic settings, results vary considerably: some patients lose 8-10% of body weight, others lose 20% or more. Factors that influence outcomes include the dose reached, consistency with the medication schedule, dietary quality, physical activity, sleep, and individual metabolic factors. At many Houston clinics, monthly check-ins are standard, and providers may adjust the treatment plan if progress stalls.

Two patients at the same Houston clinic, on identical semaglutide doses, can lose weight at completely different rates. Genetics drive a significant part of that gap. Your DNA shapes how strongly your GLP-1 receptors respond to the medication, and that's not something any dose adjustment can fully override.

Insulin resistance and type 2 diabetes tend to produce stronger early metabolic responses to semaglutide. If you've yo-yo dieted before and lost significant muscle mass, expect slower progress, less muscle means a lower resting metabolism working against you.

Sleep quality, chronic stress, and gut microbiome composition all affect how well the drug works. These aren't minor variables. They can be the difference between 8% weight loss and 15%.

Physician-supervised programs at Houston clinics can actually test for these factors through lab work and metabolic panels. Telehealth-only services typically can't. That monitoring gap matters when your results stall and you need a real answer for why.

Most patients hit a plateau at some point, typically between months 6 and 12. This is a normal physiological response, the body adapts its metabolic rate as weight decreases. Houston providers typically address plateaus by reviewing dietary intake, increasing physical activity, checking thyroid function, or discussing whether switching to or adding tirzepatide might provide additional benefit. Dose increases (when still in the titration phase) often restart progress. The key message providers across Houston give their patients: a plateau is not failure, and it's not permanent.

The STEP 4 withdrawal trial is unambiguous: when semaglutide is discontinued, most patients regain a significant portion of lost weight within 12 months. On average, participants in that trial regained 6.9% of body weight within a year of stopping, compared to 0.5% in those who continued. Houston patients who discontinue, whether for cost, side effects, or the belief that they no longer need the medication, should discuss a maintenance and monitoring plan with their provider. Some clinics in the Houston area are beginning to offer lower-dose maintenance protocols to help sustain results at reduced cost.